Ekso Bionics Holdings, Inc. Announces Resignation of Ted Wang as Member of the Board of Director
February 08, 2021 at 06:26 am EST
Share
On February 7, 2021, Ted Wang, Ph.D., a member of the Board of Directors of Ekso Bionics Holdings, Inc., tendered his resignation from the Board and all committees thereof effective February 28, 2021. Dr. Wang's decision to resign was due to increased time commitments arising from new business opportunities and not as a result of a disagreement with the Company on any matter relating to the Company's operations, policies, or practices.
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.
EKSO BIONICS HOLDINGS, INC. 
